Benefits of a Juvenile Arthritis Support Program (JASP-1) for children recently diagnosed with Juvenile Idiopathic Arthritis and their parents
Abstract Background Medical treatment for children with Juvenile Idiopathic Arthritis (JIA) has improved radically since the development of biological disease-modifying antirheumatic drugs. However, children suffer from pain and anxiety, and parents often experience loneliness and lack of support. S...
Saved in:
Main Authors: | Karina Mördrup, Johanna Granhagen Jungner, Eva Broström, Karin Palmblad, Cecilia Bartholdson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-08-01
|
Series: | BMC Rheumatology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41927-024-00404-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Benefits of a Juvenile Arthritis Support Program (JASP-1) for children recently diagnosed with Juvenile Idiopathic Arthritis and their parents
by: Karina Mördrup, et al.
Published: (2025-01-01) -
The plasma metabolome of juvenile idiopathic arthritis varies according to subtype and underlying inflammatory status
by: Jooa Kwon, et al.
Published: (2024-12-01) -
Maternal seafood intake, dietary contaminant exposure, and risk of juvenile idiopathic arthritis: exploring gene-environment interactions
by: Vilde Øverlien Dåstøl, et al.
Published: (2025-01-01) -
Atherosclerosis in Juvenile Idiopathic Arthritis
by: Ewa Jednacz, et al.
Published: (2012-01-01) -
Platelet activation markers in juvenile idiopathic arthritis
by: Pandiarajan Vignesh, et al.
Published: (2019-01-01)